A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/2004
11/10/2004	CN1174993C VEGI, an inhibitor for angiogenesis and tumor growth
11/10/2004	CN1174981C Imidazole [1,2-A] pyridine and pyrazole [2,3-a] pyridine derivatives
11/10/2004	CN1174977C Pseudo polymorph of (-)-cis-2-(2-chlorophenyl)-5, 7-dihydroxy-8[4R-(3S-hydroxy-1-methyl) piperidinyl]-4H-1-benzopyran-4-one
11/10/2004	CN1174964C Vitamin D3 Analogs
11/10/2004	CN1174772C Composite medicine for treating cancer of esophagus
11/10/2004	CN1174771C Antineoplastic injection liquid
11/10/2004	CN1174749C Tanshinone nanometer preparation and its preparing method
11/10/2004	CN1174748C New use of docetaxel for treating hepatoma
11/09/2004	US6815534 Tissue plasminogen activator-like protease
11/09/2004	US6815465 Heterocyclic compounds inhibiting angiogenesis
11/09/2004	US6815463 For therapy of disease of cellular hyperproliferation in a subject
11/09/2004	US6815462 Anticarcinogenic, viricidal, and fungicidal agents; water solubility
11/09/2004	US6815460 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors
11/09/2004	US6815451 1,2,3,4-Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists
11/09/2004	US6815442 Quinoxalinones for enhancing chemotherapy
11/09/2004	US6815441 Reaction products of taurultam and glucose
11/09/2004	US6815415 Diagnosis and treatment of malignant neoplasms
11/09/2004	US6815180 Human cervical cancer 1 protooncogene and protein encoded therein
11/09/2004	US6814981 Ganglioside immunostimulating complexes and uses thereof
11/04/2004	WO2004095023A1 Novel method of screening
11/04/2004	WO2004094629A1 Human alkaline sphingomyelinase and use thereof
11/04/2004	WO2004094476A2 Compositions and methods relating to stop-1
11/04/2004	WO2004094475A2 Tissue factor antibodies and uses thereof
11/04/2004	WO2004094462A2 Methods of peptide preparation
11/04/2004	WO2004094451A2 8&dollar;G(B)-VINYL-11&dollar;G(B)-(&dollar;G(V)-SUBSTITUTED)ALKYL-ESTRA-1,3,5(10)-TRIENES
11/04/2004	WO2004094432A1 Porphyrin compound containing biotinyl group and use thereof
11/04/2004	WO2004094424A1 Nitrogen-containing heterocyclic compounds and use thereof
11/04/2004	WO2004094416A1 7-azaindoles and use thereof as therapeutic agents
11/04/2004	WO2004094410A1 Chemical compounds
11/04/2004	WO2004094401A1 Substituted benzopyrans as selective estrogen receptor-beta agonists
11/04/2004	WO2004094400A2 Substituted benzopyrans as selective estrogen receptor-beta agonists
11/04/2004	WO2004094386A1 Isoquinoline-5-sulfonic acid amides as inhibitors of akt (protein kinase b)
11/04/2004	WO2004094376A1 Hydroxamic acids useful in the treatment of hyper-proliferative disorders
11/04/2004	WO2004093916A1 A medicament for the two-step perioperative therapy of solid tumours
11/04/2004	WO2004093911A1 Pharmaceutical composition for prostatic disease treatment
11/04/2004	WO2004093900A1 Apoptosis inducing agent and method of inducing apoptosis
11/04/2004	WO2004093889A1 Method for preparing therapeutic agent for cancer
11/04/2004	WO2004093880A1 4-anilino-quinazoline derivatives as antiproliferative agents
11/04/2004	WO2004093874A1 Use of 7-nitro-2,1,3 benzoxadiazole derivatives for anticancer therapy
11/04/2004	WO2004093868A1 Therapeutic combination of a cox-2 inhibitor and an aromatase inhibitor
11/04/2004	WO2004093858A1 Mmp expression inhibitor
11/04/2004	WO2004093856A2 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia
11/04/2004	WO2004093854A2 Antineoplastic combinations
11/04/2004	WO2004093852A2 Use of steroid derivatives for the treatment of angiotensin ii related disease e.g. cardiovascular and proliferative disorders
11/04/2004	WO2004093781A2 Podophyllotoxin derivatives as igf-1r inhibitors
11/04/2004	WO2004087673A3 Migrastatin analogs and uses thereof
11/04/2004	WO2004085436A3 Pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents
11/04/2004	WO2004080423A3 7-amino- isoindolyl compounds amd their pharmaceutical uses
11/04/2004	WO2004080271A3 Method for prognosticating the progress of breast cancer and compounds useful for prevention or treatment thereof
11/04/2004	WO2004078747A8 Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders
11/04/2004	WO2004078677A3 Enhanced delivery of sphingolipids
11/04/2004	WO2004074248A3 Isolation and structure of cribrostatin 6
11/04/2004	WO2004067762A3 Crystallized structure of type iv collagen nc1 domain hexamer
11/04/2004	WO2004067498A3 Aryl alkyl carbamate derivatives production and use thereof in therapy
11/04/2004	WO2004067480A3 Substituted phenylurea derivatives as hdac inhibitors
11/04/2004	WO2004065572A3 Proteic binding partners of tctp and methods of modulating tumor reversion or cell apoptosis
11/04/2004	WO2004050681A3 Kinase modulators
11/04/2004	WO2004039412A3 Compositions for cancer treatment
11/04/2004	WO2004004652A3 Mitotic kinesin binding site
11/04/2004	WO2003086324A3 Preparation and use of a stable formulation of allosteric effector compounds
11/04/2004	WO2003076593A3 Genomic screen for epigenetically silenced genes associated with cancer
11/04/2004	WO2003076473A8 Specific ab1'-antibodies against tumour-associated antigen ca 125
11/04/2004	WO2003060091A3 Selective melanin-concentrating hormone type -1 receptor agonists
11/04/2004	WO2003029420A3 Apo-2 ligand variants and uses thereof
11/04/2004	WO2002070675A3 Regulation of human histone acetyltransferase
11/04/2004	WO1999029693A8 Imidazonaphthyridines and their use in inducing cytokine biosynthesis
11/04/2004	US20040220408 As anti-proliferative agents, therapy
11/04/2004	US20040220388 Novel heterodimeric fusion proteins
11/04/2004	US20040220281 administering diphenyl compound; following sufficient time to permit inhibition of binding of intracellular histamine, subsequently administering a chemotherapeutic agent active in hormone-refractory prostate cancer
11/04/2004	US20040220236 4-Aryl quinols and analogs thereof as therapeutic agents
11/04/2004	US20040220204 mixture of fatty ester, alkylene carbonate, butylene glycol, diethylene glycol, monoalkyl ether and thickeners
11/04/2004	US20040220202 antiinflammatory agents; central nervous system disorders; controlling cell proliferation, cell differentiation; anticancer agents; antidepressants
11/04/2004	US20040220201 Tyrosine kinase inhibitors
11/04/2004	US20040220200 Compositions useful as protein kinase inhibitors
11/04/2004	US20040220197 Hydroanthracene based compounds as anticancer agents
11/04/2004	US20040220196 antitumor agents; 4-amino-5-fluoro-3-(6-( 4-methylpiperazin-1-yl)1H-benzimidazol-2-yl)-quinolin-2-one
11/04/2004	US20040220185 antiinflammatory agents; antiarthritic agents; anticancer agents
11/04/2004	US20040220182 tyrosine kinase inhibitor; antitumor agents
11/04/2004	US20040220181 Adhesive antineoplastic compositions
11/04/2004	US20040220171 anticoagulants; immunomoderators; antiinflammatory agents
11/04/2004	US20040220166 Half-sandwich ruthenium (II) compounds comprising nitrogen containing ligands ligands for treatment of cancer
11/04/2004	US20040220164 Triaza compound immunoregulatory agents
11/04/2004	US20040220159 osteoporosis, periodontal diseases, aging resistance, antilipemic agents, anticholesterol agents, canticancer agents, antiarthritic agents, sexual disorders
11/04/2004	US20040220148 5-Membered ring heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists
11/04/2004	US20040220092 G-protein coupled receptors
11/04/2004	US20040220086 contacting with protein which binds to cells in diseased tissue; antitumor agents
11/04/2004	US20040220083 Method for preparing polycation based bioconjugates suitable for transporting different kinds of active substances within the body
11/04/2004	US20040219672 Use of oxidised lipoproteins for differentiation of precursor cells into mature dendritic cells
11/04/2004	US20040219644 Immunoglobulin for binding monocyte chemoattractant protein-1(MCP-1) and preventing and/or treating atherosclerosis and cancer ; antitumor agents
11/04/2004	US20040219633 Method of producing recombinant antibodies
11/04/2004	US20040219226 Complex prescription of Chinese medicine for the treatment of extensive cancer
11/04/2004	US20040219224 Spherical protein particles and methods for making and using them
11/04/2004	US20040219208 Sustained-release medicines
11/04/2004	US20040219203 Anti-CD74 immunoconjugates and methods
11/04/2004	US20040219202 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety
11/04/2004	US20040219201 Tempamine compositions and methods of use
11/04/2004	US20040219181 Sustained release drug delivery devices with coated drug cores
11/04/2004	US20040219176 dosage form of a mixture of drugs, foaming agents and gases, having improved pharmacokinetics; drug delivery systems
11/04/2004	US20040219168 Preparing preferential cells from blood mononucler cells in culture; obtain monocytes, incubate with interferon; use as biodrugs treating viral infections, lymphoma, neoplastic disease induced by Epstein-Barr virus, therapeutic vaccination
11/04/2004	US20040219153 Synergistic tumorcidal response induced by histamine

1 ... 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 ... 2211